Dr. Matthew Mcbride, MD

NPI: 1871536920
Total Payments
$83,407
2024 Payments
$789.19
Companies
41
Transactions
466
Medicare Patients
2,533
Medicare Billing
$271,256

Payment Breakdown by Category

Other$70,033 (84.0%)
Food & Beverage$10,188 (12.2%)
Travel$3,162 (3.8%)
Gifts$25.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $70,033 36 84.0%
Food and Beverage $10,188 420 12.2%
Travel and Lodging $3,162 9 3.8%
Gift $25.00 1 0.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $46,275 163 $0 (2024)
Daiichi Sankyo Inc. $14,755 35 $0 (2022)
Allergan Inc. $11,042 31 $0 (2019)
E.R. Squibb & Sons, L.L.C. $3,455 2 $0 (2021)
AstraZeneca Pharmaceuticals LP $2,719 3 $0 (2017)
Janssen Scientific Affairs, LLC $689.49 6 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $462.87 25 $0 (2022)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $433.15 36 $0 (2022)
Medtronic, Inc. $329.16 2 $0 (2024)
Intercept Pharmaceuticals, Inc. $314.56 10 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $789.19 14 Medtronic, Inc. ($329.16)
2023 $281.09 2 CONMED Corporation ($281.09)
2022 $12,952 82 ABBVIE INC. ($12,109)
2021 $4,178 45 E.R. Squibb & Sons, L.L.C. ($3,455)
2020 $3,915 26 AbbVie Inc. ($3,810)
2019 $10,809 46 AbbVie, Inc. ($9,779)
2018 $8,914 104 Allergan Inc. ($3,067)
2017 $41,568 147 AbbVie, Inc. ($17,421)

All Payment Transactions

466 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
10/10/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $7.17 General
Category: GASTROENTEROLOGY
10/03/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: GASTROENTEROLOGY
08/28/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $12.60 General
Category: IMMUNOLOGY
08/06/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $122.06 General
Category: IMMUNOLOGY
08/01/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $21.01 General
Category: IMMUNOLOGY
07/24/2024 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $185.89 General
Category: Sacral Nerve Stimulation
07/23/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $17.21 General
Category: IMMUNOLOGY
05/20/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $102.08 General
Category: IMMUNOLOGY
05/07/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $6.92 General
Category: IMMUNOLOGY
03/28/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $13.95 General
Category: GASTROENTEROLOGY
03/12/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $10.29 General
Category: IMMUNOLOGY
02/28/2024 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $143.27 General
Category: Sacral Nerve Stimulation
02/27/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $11.72 General
Category: IMMUNOLOGY
02/06/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $10.02 General
Category: IMMUNOLOGY
10/23/2023 CONMED Corporation CONMED GENERATORS (Device), CONMED HEMOSTASIS, CONMED BILIARY Food and Beverage In-kind items and services $128.30 General
Category: GENERAL SURGERY
10/22/2023 CONMED Corporation CONMED BILIARY (Device) Food and Beverage In-kind items and services $152.79 General
Category: GENERAL SURGERY
12/09/2022 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $16.25 General
Category: ENDOCRINOLOGY
12/07/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $19.42 General
Category: IMMUNOLOGY
12/06/2022 Amgen Inc. AVSOLA (Biological) Food and Beverage In-kind items and services $12.05 General
Category: Inflammation
11/17/2022 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $13.35 General
Category: CRITICAL CARE
11/15/2022 Takeda Pharmaceuticals U.S.A., Inc. GATTEX (Drug) Food and Beverage In-kind items and services $22.35 General
Category: INTERNAL MEDICINE
11/03/2022 Gilead Sciences, Inc. Food and Beverage In-kind items and services $16.97 General
11/01/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $21.98 General
Category: IMMUNOLOGY
10/25/2022 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $12.25 General
Category: Immunology
10/12/2022 ABBVIE INC. VIBERZI (Drug) Food and Beverage In-kind items and services $18.50 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 209 211 $88,562 $25,050
2022 10 599 612 $373,717 $66,099
2021 15 780 802 $448,597 $84,821
2020 15 945 1,009 $507,542 $95,285
Total Patients
2,533
Total Services
2,634
Medicare Billing
$271,256
Procedure Codes
49

All Medicare Procedures & Services

49 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 43 43 $20,941 $5,959 28.5%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 29 29 $20,996 $4,870 23.2%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 17 17 $9,826 $3,449 35.1%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 24 24 $9,720 $3,084 31.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 13 13 $10,179 $2,297 22.6%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 37 37 $3,796 $2,190 57.7%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 13 13 $2,036 $1,216 59.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 19 19 $9,918 $1,172 11.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 14 16 $1,150 $813.12 70.7%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 75 75 $48,148 $13,117 27.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 98 98 $78,648 $12,325 15.7%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 62 62 $58,926 $11,763 20.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 112 120 $28,598 $7,051 24.7%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 35 35 $26,621 $4,487 16.9%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 26 26 $16,752 $4,426 26.4%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 68 70 $43,032 $3,957 9.2%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 60 60 $31,218 $3,699 11.8%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2022 33 36 $33,029 $3,106 9.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 30 30 $8,744 $2,170 24.8%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 120 121 $95,981 $15,696 16.4%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2021 78 78 $50,526 $14,139 28.0%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 55 55 $51,845 $10,915 21.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 157 174 $39,165 $10,517 26.9%
45378 Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk Facility 2021 50 50 $38,398 $6,257 16.3%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 88 88 $54,161 $5,271 9.7%

About Dr. Matthew Mcbride, MD

Dr. Matthew Mcbride, MD is a Gastroenterology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871536920.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Mcbride, MD has received a total of $83,407 in payments from pharmaceutical and medical device companies, with $789.19 received in 2024. These payments were reported across 466 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($70,033).

As a Medicare-enrolled provider, Mcbride has provided services to 2,533 Medicare beneficiaries, totaling 2,634 services with total Medicare billing of $271,256. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Oklahoma City, OK
  • Active Since 06/14/2006
  • Last Updated 12/07/2016
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1871536920

Products in Payments

  • Humira (Biological) $17,474
  • Movantik (Drug) $14,492
  • LINZESS (Drug) $9,733
  • HUMIRA (Biological) $6,756
  • SKYRIZI (Biological) $5,787
  • RINVOQ (Biological) $3,784
  • ZEPOSIA (Drug) $3,626
  • MOVANTIK (Drug) $2,600
  • VIBERZI (Drug) $1,459
  • STELARA (Biological) $761.41
  • INTERSTIM (Device) $329.16
  • GATTEX (Drug) $314.40
  • XIFAXAN (Drug) $308.62
  • Cimzia (Drug) $229.02
  • OCA (Drug) $222.00
  • INJECTAFER (Drug) $174.40
  • INFLECTRA (Biological) $153.86
  • CONMED BILIARY (Device) $152.79
  • VOQUEZNA (Drug) $146.12
  • Olympus Biliary Devices (Device) $138.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Oklahoma City